| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$54 |
Trading Halt
|
10 Mar 2026 9:12AM |
$0.230 |
$0.130 |
fallen by
43.48%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited's securities are in a trading halt.
- The trading halt is due to a pending announcement on a proposed capital raising.
- The halt will last until the announcement is made or until normal trading resumes on 12 March 2026.
- Imugene requested the halt under ASX Listing Rule 17.1.
- No other information is required to inform the market about the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| St George Mining Limited (SGQ) ORDINARY FULLY PAID |
Materials |
$434 |
Key Appointment of Principal Geologist at Araxa
|
10 Mar 2026 9:11AM |
$0.125 |
$0.110 |
fallen by
12%
|
|
SGQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Appointment of Ms. Carla Grasso as Principal Geologist.
- Focus on accelerating the Araxá Rare Earths-Niobium Project.
- Ms. Grasso has 21 years of experience, including at a nearby phosphate mine.
- Recent resource upgrade at Araxá Project boosting TREO and niobium resources.
- Araxá Project is positioned near world-leading niobium operations.
- Local government support and infrastructure aid project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitefield Income Limited (WHI) ORDINARY FULLY PAID |
Financials |
$279 |
Net Tangible Asset Backing - Feb 26
|
10 Mar 2026 9:11AM |
$1.350 |
$1.265 |
fallen by
6.30%
|
|
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,005 |
Update - Notification of buy-back - GYG
|
10 Mar 2026 9:10AM |
$18.940 |
$19.810 |
risen by
4.59%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Continued Suspension of Class from Quotation - HIQOA Only
|
10 Mar 2026 9:10AM |
$0.018 |
$0.010 |
fallen by
44.44%
|
|
| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$10,625 |
First Half Business Update
|
10 Mar 2026 9:09AM |
$21.660 |
$22.930 |
risen by
5.86%
|
|
ORI - Price-sensitive ASX Announcement
Full Release
Key Points
- Orica is not currently experiencing immediate constraints due to the Middle East conflict.
- Orica products are generally not transported through the Straits of Hormuz.
- The company is monitoring the situation and leveraging its global network to mitigate potential impacts on energy or raw material costs.
- Orica's CEO, Sanjeev Gandhi, expresses satisfaction with the strong start to the 2026 financial year.
- The company is focused on operational excellence and maintaining continuity of supply despite volatile market conditions.
- Orica remains committed to disciplined capital management and advancing growth initiatives.
- The half-year results will be announced on 7 May 2026.
- Orica aims for net zero emissions by 2050, aligning with the Paris Agreement goals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQT Holdings Limited (EQT) ORDINARY FULLY PAID |
Financials |
$435 |
Appendix 3Ys - NED Share Plan
|
10 Mar 2026 9:09AM |
$20.080 |
$16.230 |
fallen by
19.17%
|
|
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$219 |
Orthocell Appoints UK Distributor for Remplir
|
10 Mar 2026 9:08AM |
$0.800 |
$0.805 |
risen by
0.63%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for Remplir™ in the UK.
- Orthocell submitted a regulatory application to the British Standards Institution for approval to distribute Remplir in the UK/EU market.
- The UK/EU peripheral nerve repair market is valued at approximately $750 million.
- Regulatory approval for Remplir in the UK is anticipated in the third quarter of fiscal year 2026.
- LEDA Orthopaedics has extensive experience in orthopaedic technologies and maintains strong relationships with UK surgeons.
- Early distributor appointments are made to prepare for rapid commercial launch post-approval.
- Orthocell's Australian-based commercial teams will support the UK rollout, leveraging proven medical education programs.
- Remplir is already approved and selling in several countries, including Australia, New Zealand, Singapore, the US, and Hong Kong.
- Orthocell reported approximately $49 million in cash reserves as of 31 December 2025 to support its global distribution strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GPT Group (GPT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$9,156 |
Notice of Annual General Meeting/Proxy Form
|
10 Mar 2026 9:06AM |
$4.670 |
$4.780 |
risen by
2.36%
|
|
| Sports Entertainment Group Limited (SEG) ORDINARY FULLY PAID |
Communication Services |
$80 |
Notification of buy-back - SEG
|
10 Mar 2026 9:06AM |
$0.240 |
$0.285 |
risen by
18.75%
|
|
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$3,313 |
SEC Form 4
|
10 Mar 2026 9:06AM |
$20.400 |
$18.310 |
fallen by
10.25%
|
|
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$70 |
Campaign 2 Final Results Devon Pit Gold Mine
|
10 Mar 2026 9:05AM |
$0.094 |
$0.072 |
fallen by
23.40%
|
|
MAT - Price-sensitive ASX Announcement
Full Release
Key Points
- $28.74M in gold sales from Campaign 2
- 4,074 oz Au produced and sold
- Average sale price of $7,054 per oz
- 51,562 dry tonnes processed
- Head grade increased to 2.86g/t
- Recovery improved to 86.16%
- Mining for Campaign 3 to commence May 28, 2026
- Current cash balance of $18.59M
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$31 |
Update - Notification of buy-back - EPY
|
10 Mar 2026 9:05AM |
$0.155 |
$0.125 |
fallen by
19.35%
|
|
| Generation Development Group Limited (GDG) ORDINARY FULLY PAID |
Financials |
$1,628 |
Notification regarding unquoted securities - GDG
|
10 Mar 2026 9:05AM |
$4.250 |
$4.070 |
fallen by
4.24%
|
|
| Generation Development Group Limited (GDG) ORDINARY FULLY PAID |
Financials |
$1,628 |
Grant of Rights
|
10 Mar 2026 9:05AM |
$4.250 |
$4.070 |
fallen by
4.24%
|
|
| 88 Energy Limited (88E) ORDINARY FULLY PAID |
Energy |
$32 |
Completion of Small Holding Share Sale Facility
|
10 Mar 2026 9:05AM |
$0.041 |
$0.024 |
fallen by
41.46%
|
|
| Sports Entertainment Group Limited (SEG) ORDINARY FULLY PAID |
Communication Services |
$80 |
SEG Announces On-Market BuyBack
|
10 Mar 2026 9:05AM |
$0.240 |
$0.285 |
risen by
18.75%
|
|
SEG - Price-sensitive ASX Announcement
Full Release
Key Points
- Sports Entertainment Group Limited announces an on-market share buy-back.
- Up to 10% of issued ordinary shares to be bought over 12 months.
- Buy-back aims to enhance shareholder value and reflect true company value.
- Buy-back to commence on 24 March 2026.
- Purchases to be made at the company's discretion under the '10/12' limit.
- Company reserves the right to vary or terminate the buy-back.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| African Gold Limited (A1G) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holding
|
10 Mar 2026 9:04AM |
$0.920 |
$1.040 |
risen by
13.04%
|
|
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$519 |
Weekly NTA 6 March 2026
|
10 Mar 2026 9:03AM |
$1.745 |
$1.880 |
risen by
7.74%
|
|
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,020 |
AMPLIFY trial - Target number of participants achieved
|
10 Mar 2026 9:03AM |
$3.290 |
$2.740 |
fallen by
16.72%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals Ltd completed participant recruitment for AMPLIFY trial.
- AMPLIFY trial focuses on biochemical recurrence of prostate cancer.
- Trial targets 64Cu-SAR-bisPSMA PET imaging for prostate cancer recurrence detection.
- Recruitment achieved in both US and Australia, with over 220 participants enrolled.
- The trial supports a potential FDA approval for 64Cu-SAR-bisPSMA.
- AMPLIFY trial results aim to complement previous COBRA and Co-PSMA trials.
- Company emphasizes high standards of clinical research and enhanced imaging capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mammoth Minerals Limited (M79) ORDINARY FULLY PAID |
Materials |
$32 |
Acquisition of Historic Carlin Type Gold Mine, Nevada
|
10 Mar 2026 9:01AM |
$0.079 |
$0.058 |
fallen by
26.58%
|
|
M79 - Price-sensitive ASX Announcement
Full Release
Key Points
- Mammoth Minerals Limited announced an option to acquire the Imperial Gold Mine in Nevada.
- The Imperial Mine is located 5km from Mammoth’s Excelsior Project.
- The mine is a Carlin Type gold deposit with high-grade production history.
- Imperial Mine remains open at depth with numerous drill targets.
- Mammoth has expanded its land package to 135 km2.
- The acquisition strategy includes a substantial exploration program.
- Imperial Mine was originally developed in the 1920s.
- Significant historical production and exploration results support further development.
- The mine features multiple gold opportunities and high-grade veins.
- Mammoth is focusing on exploring and integrating the Imperial Mine with its Excelsior Gold and Blue Dick silver projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$91 |
Amended - Change in substantial holding for MFD
|
10 Mar 2026 9:01AM |
$0.485 |
$0.445 |
fallen by
8.25%
|
|
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$24 |
Amended - Change in substantial holding from EVO
|
10 Mar 2026 9:01AM |
$0.425 |
$0.315 |
fallen by
25.88%
|
|
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,066 |
Update - Notification of buy-back - FLT
|
10 Mar 2026 9:00AM |
$11.900 |
$10.020 |
fallen by
15.80%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$748 |
Application for quotation of securities - PPM
|
10 Mar 2026 9:00AM |
$2.210 |
$1.665 |
fallen by
24.66%
|
|
Call 1300 880 160
Start a chat
Schedule a call
